Volta Labs has filed a notice of an exempt offering of securities to raise $9,000,001.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Volta Labs is raising up to $9,000,001.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Udayan Umapathi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Volta Labs
Volta is building a sequencing technology agnostic platform that revolutionizes the entire sample prep process from raw biological samples to sequenceable molecules. As a collective of scientists and builders working at the intersection of engineering and biology, we imagine a world where extracting vital information from biological samples is as simple as pressing a button. Thats our vision, and were turning it into reality. Our HQ is in Bostons Seaport, where we design and build our hardware and develop the software that powers it from our own lab. We believe in cross-functional collaboration and continuous learning whether your interest is in biology, MechEng, CompEng, or simply joining a fast-growing startup striving to make the world a better place, Volta is looking to welcome you to our team. Check out some of our blog posts to learn more about work life at Volta.
To learn more about Volta Labs, visit http://voltalabs.com/
Contact:
Udayan Umapathi, Chief Executive Officer
857-204-3661
https://www.linkedin.com/in/udayanu/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.